A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Overview of attention for article published in New England Journal of Medicine, May 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 32 news outlets
blogs: 7 blogs
policy: 6 policy sources
twitter: 54 X users
patent: 75 patents
weibo: 4 weibo users
facebook: 4 Facebook pages

wikipedia: 12 Wikipedia pages
reddit: 1 Redditor
f1000: 1 research highlight platform
video: 1 YouTube creator
guideline: 12 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 1756 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 59 X posts from 54 X users, with an upper bound of 1,161,485 followers.

RT @DocMusician: Estudio ascend: https://t.co/lVkTaJ3OUd

Estudio ascend: https://t.co/lVkTaJ3OUd

RT @SamaherHashim: IPF: ( ASCEND, INPULSIS, INSTAGE, PANTHER-IPF) https://t.co/Qr9ANlXWxc https://t.co/zG0VKZxc0j https://t.co/sFofjQ9G…

IPF: ( ASCEND, INPULSIS, INSTAGE, PANTHER-IPF) https://t.co/Qr9ANlXWxc https://t.co/zG0VKZxc0j https://t.co/sFofjQ9Gpv https://t.co/I71GOQpTNb

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 55 additional X posts.